Markets had been unsettled by U.S. President Donald Trump's announcement of sweeping trade tariffs last week, stoking fears of a global recession. Trump said on Monday he would talk to China, Japan and other countries over the tariffs, but was not looking at a pause on the duties. Separately, data from funds network Calastone showed British investors had piled into U.S. stocks in the weeks before Trump's tariff announcement.
Global stocks are rebounding Tuesday as some investors take advantage of recent massive losses, even as China threatened to hit back further if President Donald Trump hikes U.S. import tariffs by an additional 50%.
Meghan, Duchess of Sussex, talks to Fortune about launching consumer brand As Ever and the release of her new podcast, right as tariffs rock the markets.
(Bloomberg) -- Supply Lines is a daily newsletter that tracks global trade. Sign up here.Most Read from BloombergThe Irish Hot Press Is the Low-Tech Laundry Trick the World NeedsThis Skinny Mexico City Tower Is Just 14 Feet Wide on One SideHousing Agency Aims to Relocate Its DC HeadquartersTrump Order on CDFI Fund Risks Aid for Small Businesses, HousingBoston Mayor Wu Embraces Trump Resistance as Campaign Heats UpChina pledged to retaliate against Donald Trump’s latest tariff threat and mobilize
Medicare-focused insurer Humana led gains with a 16% jump, while other health insurers including UnitedHealth Group, Centene and CVS Health advanced between 5% and 10%. The 5.06% average increase, more than double what the government proposed in January, could help profit margins in the sector after a post-COVID surge in demand for medical procedures drove up costs.
The idea revealed in the wishful thinking-turned-market action is that there's no secret to what's needed for a market turnaround.
Money market account interest rates today are still well above historical norms. Find out where to get the best money market account rates now.
U.S. Treasuries extended a sharp retreat on Tuesday as investors were having to sell bonds to cover losses in other assets and scrambled to unwind expectations for deep U.S. rate cuts, in the latest unsettling sign of possible stress in financial markets. Monday's range for the benchmark 10-year yield was one of the largest in the past two decades while expectations evaporated that the Federal Reserve would start cutting interest rates within weeks to offset the economic pain caused by huge U.S. import tariffs. Market participants said the scale of moves and uncertainty in Fed funds futures trade was unprecedented, as pricing for 130 basis points of U.S. rate cuts this year collapsed to 92 bps in a matter of hours.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how home construction materials stocks fared in Q4, starting with Simpson (NYSE:SSD).
The past six months haven’t been great for Sarepta Therapeutics. It just made a new 52-week low of $52, and shareholders have lost 56.6% of their capital. This may have investors wondering how to approach the situation.